IBDEI0GE ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7354,1,4,0)
 ;;=4^F19.120
 ;;^UTILITY(U,$J,358.3,7354,2)
 ;;=^5003417
 ;;^UTILITY(U,$J,358.3,7355,0)
 ;;=F15.220^^36^365^82
 ;;^UTILITY(U,$J,358.3,7355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7355,1,3,0)
 ;;=3^Substance Dependence,Oth Stimulant w/ Intoxication,Uncomplicated
 ;;^UTILITY(U,$J,358.3,7355,1,4,0)
 ;;=4^F15.220
 ;;^UTILITY(U,$J,358.3,7355,2)
 ;;=^5003297
 ;;^UTILITY(U,$J,358.3,7356,0)
 ;;=R56.9^^36^365^81
 ;;^UTILITY(U,$J,358.3,7356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7356,1,3,0)
 ;;=3^Seizure Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,7356,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,7356,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,7357,0)
 ;;=Z93.0^^36^365^91
 ;;^UTILITY(U,$J,358.3,7357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7357,1,3,0)
 ;;=3^Tracheostomy status
 ;;^UTILITY(U,$J,358.3,7357,1,4,0)
 ;;=4^Z93.0
 ;;^UTILITY(U,$J,358.3,7357,2)
 ;;=^5063642
 ;;^UTILITY(U,$J,358.3,7358,0)
 ;;=I47.2^^36^365^92
 ;;^UTILITY(U,$J,358.3,7358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7358,1,3,0)
 ;;=3^Ventricular tachycardia
 ;;^UTILITY(U,$J,358.3,7358,1,4,0)
 ;;=4^I47.2
 ;;^UTILITY(U,$J,358.3,7358,2)
 ;;=^125976
 ;;^UTILITY(U,$J,358.3,7359,0)
 ;;=N17.9^^36^365^2
 ;;^UTILITY(U,$J,358.3,7359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7359,1,3,0)
 ;;=3^Acute kidney failure,unspc
 ;;^UTILITY(U,$J,358.3,7359,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,7359,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,7360,0)
 ;;=Z72.0^^36^365^90
 ;;^UTILITY(U,$J,358.3,7360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7360,1,3,0)
 ;;=3^Tobacco Use
 ;;^UTILITY(U,$J,358.3,7360,1,4,0)
 ;;=4^Z72.0
 ;;^UTILITY(U,$J,358.3,7360,2)
 ;;=^5063255
 ;;^UTILITY(U,$J,358.3,7361,0)
 ;;=E87.6^^36^365^46
 ;;^UTILITY(U,$J,358.3,7361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7361,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,7361,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,7361,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,7362,0)
 ;;=E87.1^^36^365^47
 ;;^UTILITY(U,$J,358.3,7362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7362,1,3,0)
 ;;=3^Hyponatremia
 ;;^UTILITY(U,$J,358.3,7362,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,7362,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,7363,0)
 ;;=E87.5^^36^365^40
 ;;^UTILITY(U,$J,358.3,7363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7363,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,7363,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,7363,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,7364,0)
 ;;=E87.0^^36^365^44
 ;;^UTILITY(U,$J,358.3,7364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7364,1,3,0)
 ;;=3^Hypernatremia
 ;;^UTILITY(U,$J,358.3,7364,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,7364,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,7365,0)
 ;;=I48.20^^36^365^6
 ;;^UTILITY(U,$J,358.3,7365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7365,1,3,0)
 ;;=3^Atrial Fibrillation,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,7365,1,4,0)
 ;;=4^I48.20
 ;;^UTILITY(U,$J,358.3,7365,2)
 ;;=^5158048
 ;;^UTILITY(U,$J,358.3,7366,0)
 ;;=N18.30^^36^365^21
 ;;^UTILITY(U,$J,358.3,7366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7366,1,3,0)
 ;;=3^CKD Stage 3,Unspec
 ;;^UTILITY(U,$J,358.3,7366,1,4,0)
 ;;=4^N18.30
 ;;^UTILITY(U,$J,358.3,7366,2)
 ;;=^5159286
 ;;^UTILITY(U,$J,358.3,7367,0)
 ;;=N18.31^^36^365^22
 ;;^UTILITY(U,$J,358.3,7367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7367,1,3,0)
 ;;=3^CKD Stage 3a
 ;;^UTILITY(U,$J,358.3,7367,1,4,0)
 ;;=4^N18.31
